The VA selected Abridge on September 22, 2026 for a five-year, $775.72 million enterprise contract to expand ambient AI documentation tools across veterans' health care, building on a pilot already running in more than 75 medical centers.
Nutrition scientist Betty Murray has built an AI platform aiming to personalize menopause care and finally generate the large-scale real-world data on midlife women's health that clinical medicine has long lacked, D CEO reports.
A September 2026 UCLA Health review in the Journal of Breast Imaging found AI tools can retrospectively flag 5-78% of interval breast cancers missed at prior mammograms, but researchers caution that clinical benefit for patients remains unproven.
The FDA cleared Momentis Surgical's Anovo system for traditional multiport surgery on July 23, 2026, making it the first robotic platform authorized to perform natural-orifice, single-port, and multiport procedures, intensifying competition with Intuitive Surgical's dominant da Vinci line.
A study of Abridge's AI scribe across 20 Sutter Health hospitals found physicians used it for less than half their notes and only 53% reported strong success — a sobering data point as ambient AI expands from outpatient clinics into inpatient wards.
Spectral AI is presenting validation data at the ACS Clinical Congress on its DeepView System, an FDA-cleared device that uses AI and multi-spectral imaging to predict within 25 seconds whether a burn wound will heal on its own or need surgery.
Bloomberg reports Apple is developing a home security camera and monitoring service for 2027 that analyzes surroundings using on-device AI rather than storing traditional video, alongside a smart home hub due before the end of 2026.
UpDoc has won FDA clearance for the first Software as a Medical Device built on a patient-facing large language model, an insulin-titration app for type 2 diabetes now backed by $18 million in seed funding and running at Cleveland Clinic, Allegheny Health Network and UCSF Health.
The FDA's Digital Health Advisory Committee is weighing how to regulate AI therapy chatbots after Woebot's 2025 shutdown exposed the gap, while patient-safety group ECRI has named the chatbots the top health technology hazard of 2026.
Oura filed to go public on September 4, 2026, targeting a valuation above $16 billion and citing nearly 42 billion hours of physiological data behind its AI health models, even as a class-action lawsuit challenges the accuracy of its sleep-stage tracking.